The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

DexCom Inc

Nasdaq: DXCM
Last

(U.S.) $64.38

Today's change-1.58 -2.40%
Updated April 29 4:00 PM EDT. Delayed by at least 15 minutes.
 

DexCom Inc

Nasdaq: DXCM
Last

(U.S.) $64.38

Today's change-1.58 -2.40%
Updated April 29 4:00 PM EDT. Delayed by at least 15 minutes.

DexCom Inc crosses below 50-day moving average

DexCom Inc closed sharply lower Friday, dropping (U.S.)$1.58 or 2.40% to (U.S.)$64.38 and crossing below its 50-day moving average. Over the last five days, shares have lost 5.92% and are down 21.39% for the last year to date. This security has underperformed the S&P 500 by 2.12% during the last year.

Key company metrics

  • Open(U.S.) $65.67
  • Previous close(U.S.) $65.96
  • High(U.S.) $65.67
  • Low(U.S.) $62.64
  • Bid / Ask(U.S.) $61.08 / (U.S.) $65.00
  • YTD % change-21.39%
  • Volume1,155,589
  • Average volume (10-day)696,389
  • Average volume (1-month)768,464
  • Average volume (3-month)907,394
  • 52-week range(U.S.) $47.92 to (U.S.) $103.29
  • Beta0.39
  • Trailing P/ENegative, not meaningful
  • P/E 1 year forwardNegative, not meaningful
  • Forward PEGNegative, not meaningful
  • Indicated annual dividend--
  • Dividend yield0.00%
  • Trailing EPS(U.S.) -$0.79
Updated April 29 4:00 PM EDT. Delayed by at least 15 minutes.
S&P TSX0.47%Sector:HealthcareIndustry:Medical Equipment, Supplies & Distribution

Latest Press Releases

View more Press Releases
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q1/2016Q4/2015Q3/2015Q2/2015
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedMar 31, 201603/31/2016Dec 31, 201512/31/2015Sep 30, 201509/30/2015Jun 30, 201506/30/2015
Revenue11613110593
Total other revenue--------
Total revenue11613110593
Gross profit75917566
Total cost of revenue41403127
Total operating expense13512914897
Selling / general / administrative62615245
Research & development32296524
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)--------
Other operating expenses, total--------
Operating income-192-42-4
Interest income (expense), net non-operating0000
Gain (loss) on sale of assets--------
Other--------
Income before tax-192-43-4
Income after tax-192-43-4
Income tax, total--0----
Net income-192-43-4
Total adjustments to net income--------
Net income before extra. items-192-43-4
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items-192-43-4
Inc. avail. to common incl. extra. items-192-43-4
Diluted net income-192-43-4
Dilution adjustment--0----
Diluted weighted average shares82828180
Diluted EPS excluding extraordinary itemsvalue per share-0.230.02-0.53-0.05
Dividends per sharevalue per share0.00--0.000.00
Diluted normalized EPSvalue per share-0.230.02-0.53-0.05